Jessica Berlier

Director P&AD • Catalent Cell & Gene Therapy

Jessica is a seasoned professional with a strong background in process and analytical development within the pharmaceutical and biotechnology industry. Her journey showcases her growth and contributions in various roles, making her a notable figure in the field.

Jessica currently holds the position of Director Process and Analytical Development | Cell Therapy at Catalent Pharma Solutions. In this capacity, she leads teams and initiatives focused on advancing cell therapy processes and analytical techniques. Her experience at Catalent spans several years, progressively moving from roles like Senior Process and Analytical Development Leader to her current leadership position. Her commitment to excellence is evident in her contributions to the development and improvement of processes critical to cell therapy.

Prior to her work at Catalent, Jessica was an integral part of MaSTherCell, where she served as a Production Development Supervisor. She also made significant contributions as a Research Fellow at the Cancer Science Institute of Singapore, studying the relationship between the bone marrow niche and multiple myeloma development.

Jessica’s academic journey includes a PhD in Biomedical and Pharmaceutical Science from Université libre de Bruxelles, where she delved into topics related to stem cell viability and metabolism. Her earlier research experience, including her Master’s Degree Internship at CNRS, honed her expertise in structural study and characterization.

Jessica’s dynamic career path underscores her dedication to advancing the field of biopharmaceuticals, particularly in cell therapy and process development. Her progressive roles and research accomplishments position her as a valuable leader and contributor in the industry.

Also speaking

Dorothea Ledergerber

Chief Technical Officer • Tigen Pharma

Matthew Lakelin

Vice President, Scientific Affairs & Product Development, Co-Founder • Trakcel

Mantej Chhina

Executive Director, Head of Global R&D Regulatory Policy • BioMarin

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.